Investigations on a series of heterocyclic hemicholinium-3 analogs.
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D002794:Choline / Q000494:pharmacology; D002800:Cholinesterase Inhibitors; D003650:Decamethonium Compounds / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects; D051379:Mice; D009132:Muscles / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects*; D010276:Parasympatholytics / Q000494:pharmacology* / Q000633:toxicity; D010830:Physostigmine / Q000494:pharmacology; D011817:Rabbits; D012584:Sciatic Nerve / Q000187:drug effects; D013237:Stereoisomerism; D013390:Succinylcholine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*
D002800:Cholinesterase Inhibitors; D003650:Decamethonium Compounds; D010276:Parasympatholytics; D010830:Physostigmine; D013390:Succinylcholine; D002794:Choline